Indigo Capital has acquired a minority stake in Vivason
May 2026 — Indigo Capital has acquired a minority stake in Vivason, a leading network of hearing care centers, to support the company’s growth and enable management to increase its ownership stake.
Indigo Capital is an independent private equity firm headquartered in Paris and Lyon that partners with entrepreneurs, management teams and families to accelerate growth and strengthen their businesses. The firm focuses on lower mid-cap investments, typically ranging from US$8 million to US$46 million, helping high-potential small and medium-sized enterprises (SMEs) scale into leading European mid-sized companies.
Vivason is a network of hearing care centers specializing in audiology services, offering hearing assessments, fittings for leading hearing aid brands and personalized follow-up care. The company differentiates itself through transparent and competitive pricing, making hearing solutions more accessible across France.
Clariane is a European care services group supporting people in vulnerable situations through three main activities: care homes; healthcare facilities and services; and home and alternative living solutions. The group operates across several European countries and provides long-term and specialty care services, including post-acute rehabilitation and mental health services.
Our role in the transaction
Oaklins’ team in France acted as the buy-side advisor to Indigo Capital in its minority investment in Vivason.
Talk to the deal team
Related deals
Cibus has acquired Aweta from Standard Investment
Standard Investment has reached an agreement with Cibus Capital, advisor to the Cibus funds, on the sale of Aweta, a global leader in fruit and vegetable sorting, grading and packing equipment. Completion of the transaction is expected in the coming weeks. The transaction provides Aweta with a strong partner to support the company’s next growth phase. Under Cibus’ ownership, Aweta will pursue further international growth and accelerate investment in R&D, supporting the installed base and product innovation, including software and AI capabilities. Aweta’s leadership team will continue to lead the business.
Learn moreKatalyst Diagnostics has been acquired by Cruinn Diagnostics
Katalyst Diagnostics Ltd. has been acquired by Cruinn Diagnostics Ltd. The acquisition strengthens Cruinn Diagnostics’ presence in the UK diagnostics market, adding established NHS customer relationships, local commercial infrastructure and a complementary portfolio of point-of-care diagnostic solutions. It also creates opportunities to introduce Cruinn Diagnostics’ products to UK customers while leveraging its established Irish platform to accelerate the growth of Katalyst Diagnostics’ portfolio in Ireland. With more than 100 employees and revenues in excess of US$56 million, the combined business will continue to focus on the UK market, where Cruinn Diagnostics sees significant opportunities to expand through further investment and targeted M&A.
Learn moreGroGlass has been acquired by Apogee Enterprises
Apogee Enterprises, Inc. (Nasdaq: APOG), a leading US provider of architectural building products, services and high-performance coated materials, has acquired GroGlass, a Latvia-based developer and manufacturer of high-performance anti-reflective and UV-protective glass coatings. The acquisition brings GroGlass’ differentiated coating technologies and materials science expertise into Apogee’s performance surfaces segment, broadening its product offering and market reach while expanding its manufacturing and R&D presence in Europe.
Learn more